Overview
Thromboangiitis obliterans (TAO), commonly called Buerger's disease, is a rare but devastating condition that blocks small‑ and medium‑sized arteries in the lower legs. When medical therapy fails, many patients face chronic pain, non‑healing toe ulcers, and the looming threat of amputation. A small prospective series from 2019‑2021 explored whether a specialized version of distraction osteogenesis could restore blood flow and relieve symptoms. The study used the classic Ilizarov technique to perform a lateral tibial corticotomy followed by horizontal distraction.
Understanding this approach matters because it offers a cost‑effective, limb‑saving alternative to more invasive revascularization surgery or amputation. The results—pain relief in eight of ten patients and improved walking distance in most—suggest that bone‑based angiogenesis could become a viable option for carefully selected individuals.
What This Study Examined
The investigators enrolled ten adults with confirmed TAO who had not improved after maximal pharmacologic therapy. Each patient underwent a lateral tibial corticotomy and then a controlled 2.5 cm horizontal distraction using an Ilizarov two‑ring frame. Distraction began ten days post‑op at 0.25 mm every six hours for 25 days. After the newly formed bone consolidated, the frame was removed.
Why This Matters for Patients
For individuals living with Buerger's disease, the primary goals are to eliminate rest pain, heal ischemic ulcers, and preserve the limb. Traditional options—smoking cessation, vasodilators, or bypass grafts—often fall short, especially when distal vessels are completely occluded. The Ilizarov method leverages the body’s own regenerative capacity, encouraging fresh blood‑vessel growth (neoangiogenesis) through mechanical tension. If successful, patients can avoid amputation, regain functional mobility, and experience a better quality of life.
Medical Background
Buerger's disease predominantly affects young male smokers, though women and non‑smokers can be affected. The disease causes chronic ischemia manifested as claudication (pain on walking), rest pain, and distal ulceration or gangrene. Because the occlusion is at the level of the digital arteries, conventional revascularization is often impossible.
The Ilizarov method, pioneered by Ilizarov, is best known for limb‑lengthening and deformity correction. The principle of distraction osteogenesis also increases surrounding vascularity. By creating a controlled fracture (corticotomy) and slowly moving the bone segments apart, a cascade of biological responses is triggered, including angiogenesis, osteogenesis, and soft‑tissue expansion.
How the Procedure Works
1. Pre‑operative planning: Detailed radiographs and duplex ultrasonography confirm that the tibia is suitable for corticotomy and that the limb is otherwise salvageable.
2. Linear tibial corticotomy: A small lateral incision exposes the tibia; using an osteotome, a thin cortical window is created without completely separating the bone.
3. External fixator application: Two circular rings are attached to the tibia with tensioned olive wires and half‑pins. The rings are linked by a horizontal distraction device.
4. Latency period: The device remains inactive for about 10 days to allow early callus formation.
5. Distraction phase: The limb is lengthened 0.25 mm every six hours, totaling ~2.5 cm over 25 days. This gradual stretch stimulates new bone formation (callotasis) and induces neoangiogenesis in the surrounding soft tissue.
6. Consolidation phase: After reaching the target distraction, the frame stays in place while the regenerate bone matures, usually 2–3 months.
7. Frame removal: Once radiographic evidence of solid bone is seen, the frame is removed, and the patient begins physiotherapy.
Who Is a Candidate?
The ideal candidate is a patient with documented TAO who:
- Has persistent rest pain, claudication, or ulceration despite cessation of smoking and maximal medical therapy.
- Has a viable tibia (no severe osteoporosis or infection) suitable for corticotomy.
- Is motivated to comply with a prolonged external‑fixator regimen, including pin‑site care.
- Does not have active infection at the intended surgical site or systemic conditions that impair bone healing (e.g., uncontrolled diabetes).
Patients must understand that the procedure does not replace the need for smoking cessation; continued tobacco use dramatically reduces the chance of success.
Clinical Summary
- Procedure: Lateral tibial corticotomy with horizontal distraction using an Ilizarov circular external fixator.
- Typical Duration: Distraction phase ~25 days; consolidation phase 2–3 months; total treatment ~3–4 months.
- Recovery: Pin‑site hygiene, weight‑bearing as tolerated, physiotherapy for gait training; full return to ambulation usually within 4–6 weeks after frame removal.
- Success Rate (general): In the reported series, 80 % achieved complete pain relief and improved walking distance (Source: PubMed / Europe PMC).
Study Methodology
The investigators performed a prospective case series from 2019 to 2021 at a tertiary care hospital. Ten patients (median age 38 years; 9 men, 1 woman) with radiologically and clinically confirmed TAO were included. All had failed conventional medical management, including smoking cessation counseling, calcium channel blockers, and prostaglandin analogues.
Patient Selection Criteria
- Age 18–55 years.
- Documented distal arterial occlusion consistent with TAO (no atherosclerotic risk factors other than smoking).
- Persistent rest pain or ulceration > 3 months despite optimal pharmacologic therapy.
- Intact tibial shaft suitable for corticotomy.
Outcome Measures
Primary outcomes were pain relief (graded on a visual analogue scale), claudication distance, and ulcer healing. Secondary outcomes included pin‑site infection rates, time to bone consolidation, and the need for amputation. Follow‑up visits occurred at 1 month, 3 months, and 6 months post‑frame removal.
Results & Findings
All ten patients completed the distraction protocol. The average achieved distraction was 2.5 cm (range 2.3–2.6 cm). Radiographs demonstrated satisfactory regenerate bone formation in nine patients; one patient showed delayed consolidation, which eventually united after prolonged fixation.
Key Outcomes
- Pain relief: Eight patients (80 %) reported being completely pain‑free; one patient experienced partial relief; one patient’s condition deteriorated and required a below‑knee amputation.
- Claudication distance: Improved in nine patients; the amputated patient, unsurprisingly, could not be assessed.
- Ulcer healing: All surviving patients achieved complete ulcer resolution by the final follow‑up.
- Bone regeneration: Nine of ten patients showed timely consolidation; one patient required an additional 4 weeks of fixation.
Complications & Risks
- Pin‑site infection occurred in three patients (30 %); all responded to oral antibiotics and local dressing changes.
- Delayed bone consolidation in one patient (10 %).
- One case of worsening ischemia leading to below‑knee amputation (10 %).
- General risks of Ilizarov fixation include neurovascular injury, joint stiffness, and discomfort from the external apparatus.
Despite these complications, the overall limb‑salvage rate was 90 % in this small cohort (Source: PubMed / Europe PMC).
Key Takeaways for Patients
- The Ilizarov horizontal distraction technique can trigger new blood‑vessel growth, relieving pain and healing ulcers in many patients with TAO.
- Success is highest when you quit smoking completely; continued tobacco use markedly reduces bone healing and angiogenesis.
- Expect to wear an external fixator for about three months, with daily pin‑site care and regular follow‑up visits.
- Common minor complications include pin‑site infections, which are usually treatable with oral antibiotics.
- Discuss with your surgeon the likelihood of pain relief, the need for strict smoking cessation, and the rehabilitation plan after frame removal.
Questions to ask your surgeon:
- What is my individual chance of pain relief and ulcer healing with this procedure?
- How will my smoking status affect the outcome?
- What is the detailed schedule for distraction and how will I monitor progress?
- What pin‑site care protocol will I need to follow?
- What rehabilitation and physiotherapy support will be available after the frame is removed?
Frequently Asked Questions
- Is Ilizarov distraction surgery painful?
- The corticotomy is performed under regional or general anesthesia, so the operation itself is not painful. Distraction is gradual and usually well tolerated; some patients feel mild stretching sensations, which are managed with analgesics.
- Can this procedure replace smoking cessation?
- No. Stopping tobacco use is essential; smoking impairs bone regeneration and angiogenesis, dramatically lowering the chance of a successful outcome.
- How long will I need to wear the external fixator?
- The fixator remains for the distraction phase (about 25 days) plus the consolidation phase (typically 2–3 months). Total wear time is roughly 3–4 months.
- What are the signs of a pin‑site infection?
- Redness, swelling, drainage, or increasing pain around a pin are warning signs. Early treatment with oral antibiotics and proper dressing usually resolves the issue.
- Will I be able to walk while the frame is on?
- Most patients can bear weight as tolerated and use crutches or a walker. Physical therapy is started early to maintain muscle strength and joint range of motion.